China Oncology ›› 2024, Vol. 34 ›› Issue (9): 890-902.doi: 10.19401/j.cnki.1007-3639.2024.09.009
• Guideline and Concensus • Previous Articles
Committee of Integrated Rehabilitation for Urogenital Tumors, Chinese Anti-Cancer Association
Received:
2024-07-02
Revised:
2024-09-09
Online:
2024-09-30
Published:
2024-10-11
Share article
CLC Number:
Committee of Integrated Rehabilitation for Urogenital Tumors, Chinese Anti-Cancer Association. Chinese expert consensus on perioperative integrated rehabilitation for radical prostatectomy (2024 edition)[J]. China Oncology, 2024, 34(9): 890-902.
"
研究类型 | 纳入患者数 | 干预措施 | 主要结果 | 证据级别 | 推荐级别 |
---|---|---|---|---|---|
RCT[ | 180 | 术前+术后PFMT vs 术后PFMT | 术前3周PFMT并未明显缩短术后尿失禁持续时间 | 中等质量 | 强推荐 |
Meta分析[ | 1 108 | PFMT中:有生物反馈 vs 无生物反馈 | 客观测量发现生物反馈辅助PFMT对尿失禁的早期、中期和长期治疗影响显著(P=0.023、0.002和0.017)。主观测量发现生物反馈辅助PFMT对尿失禁的中期和长期治疗影响显著(P=0.034、0.005) | 高质量 | 强推荐 |
Meta分析[ | 4 256 | 17种治疗搭配方案 | 生物反馈+专业治疗师指导治疗在术后1~6个月时对尿失禁的早期恢复表现出优越的疗效,而电神经刺激疗法在术后3个月左右对尿失禁的恢复表现出优越的疗效。术后12个月,除电神经刺激疗法+生物反馈+专业治疗师指导治疗外,其余治疗方式的差异均无统计学意义 | 高质量 | 强推荐 |
"
研究类型 | 纳入患者 | 干预措施 | 主要结果 | 证据级别 | 推荐级别 |
---|---|---|---|---|---|
RCT[ | 72 | PFMT* | 实验组在3、6、9和12个月时性功能障碍的患病率分别为94.3%、88.6%、82.9%和65.7%,对照组分别为100.0%、100.0%、96.3%和92.6%。实验组和对照组在6和12个月时差异有统计学意义(P<0.05) | 中等质量 | 一般推荐 |
RCT[ | 52 | PFBT# | 术后两组患者的IIEF-5评分均显著下滑,但随时间逐渐回升,其中PEBT治疗组回升更为显著,且有效率高于对照组(47.1% vs 12.5%),勃起功能障碍的绝对风险降低了34.6%(95% CI:3.8~64.0) | 中等质量 | 强推荐 |
RCT[ | 52 | 术前生物反馈物理治疗△ | 对照组术后尿失禁和勃起功能障碍发生率分别为100.0%和48.6%,显著高于实验组的5.0%和5.0%(P<0.000 1) | 中等质量 | 一般推荐 |
"
共识内容 | 证据级别 | 推荐强度 |
---|---|---|
围手术期加速康复 | ||
RP前需要对患者进行心理评估和患者教育 | 中 | 一般 |
术前需对患者进行营养状态评估,并进行营养支持以改善营养状态 | 高 | 强 |
根据患者情况,术前进行简单、迅速的肠道准备即可 | 高 | 强 |
营养状态不佳的患者应根据情况进行ONS,更严重者应推迟手术 | 中 | 强 |
术前禁食时间为6 h,禁饮时间为2 h,但要警惕术中误吸风险 | 高 | 一般 |
患者术后应早期恢复饮食,并减少麻醉镇痛泵的使用 | 中 | 强 |
术后不推荐无差别止痛,应根据患者情况进行阶梯式疼痛干预 | 低 | 强 |
RP后尿失禁 | ||
针对术后拔除尿管早期出现的尿失禁,以基本情况评估、记录为主。对于长时间保守治疗未恢复的患者推荐进行更明确的检查 | 中 | 一般 |
推荐患者调整生活和运动方式,以促进尿失禁的恢复 | 中 | 一般 |
行为治疗是术后促进尿失禁恢复的主要手段,如凯格尔运动,建议在专业的医师指导下进行 | 高 | 强 |
建议术前即开始PFMT,以促进术后的尿控恢复 | 高 | 强 |
术后的训练时机一般在拔除尿管后开始 | 高 | 强 |
一些辅助治疗可以促进尿失禁的恢复 | 中 | 一般 |
RP后勃起功能障碍 | ||
应该在术前即对所有患者进行勃起功能状态评分,并在术后提供主动咨询和评估,对于有支持干预需要的患者进行治疗 | 中 | 强 |
术中保留神经的患者,长时间口服PDE5抑制剂对恢复勃起功能有所帮助 | 高 | 强 |
RP后饮食 | ||
术后饮食恢复应由半流质饮食开始逐步恢复,并注意蛋白和维生素的补充 | 低 | 强 |
康复期患者应通过饮食和运动避免体重快速增加 | 低 | 一般 |
RP后运动 | ||
围手术期及术后应尽早开展个性化有氧耐力和适度力量训练 | 低 | 一般 |
术后第1天即鼓励患者下床活动,并制定计划逐步增加活动强度 | 低 | 一般 |
心理支持 | ||
对患者应积极开展心理支持,并鼓励亲属和朋友参与 | 低 | 一般 |
教育和社会支持 | ||
充分的社会支持是鼓励患者返回社会,积极面对疾病的重要方法 | 低 | 强 |
[1] | RICK O, BÖCKMANN J, DAUELSBERG T, et al. Rehabilitation of prostate cancer patients: a multidisciplinary consensus[J]. Urologe A, 2016, 55(7): 933-939. |
[2] | XU Y, LIU A, CHEN L, et al. Enhanced recovery after surgery (ERAS) pathway optimizes outcomes and costs for minimally invasive radical prostatectomy[J]. J Int Med Res, 2020, 48(6): 300060520920072. |
[3] |
ZHAO Y R, ZHANG S B, LIU B J, et al. Clinical efficacy of enhanced recovery after surgery (ERAS) program in patients undergoing radical prostatectomy: a systematic review and meta-analysis[J]. World J Surg Oncol, 2020, 18(1): 131.
doi: 10.1186/s12957-020-01897-6 pmid: 32552894 |
[4] | CERANTOLA Y, VALERIO M, PERSSON B, et al. Guidelines for perioperative care after radical cystectomy for bladder cancer: Enhanced Recovery After Surgery (ERAS®) society recommendations[J]. Clin Nutr, 2013, 32(6): 879-887. |
[5] | 中国医师协会麻醉学医师分会, 中国医师协会泌尿外科医师分会. ERAS中国专家共识暨路径管理专家共识(2018):前列腺癌根治手术部分[J]. 临床麻醉学杂志, 2018, 34(6): 602-608. |
Anesthesiologists Branch of Chinese Medical Doctor Association, Urologists Branch of Chinese Medical Doctor Association. ERAS China expert consensus and path management expert consensus (2018): radical prostate cancer surgery[J]. J Clin Anesthesiol, 2018, 34(6): 602-608. | |
[6] |
SUGI M, MATSUDA T, YOSHIDA T, et al. Introduction of an enhanced recovery after surgery protocol for robot-assisted laparoscopic radical prostatectomy[J]. Urol Int, 2017, 99(2): 194-200.
doi: 10.1159/000457805 pmid: 28222423 |
[7] |
WEIMANN A, BRAGA M, CARLI F, et al. ESPEN guideline: clinical nutrition in surgery[J]. Clin Nutr, 2017, 36(3): 623-650.
doi: S0261-5614(17)30063-8 pmid: 28385477 |
[8] | 陈慧, 刘存明. 胃部超声在胃排空延迟患者麻醉中的应用进展[J]. 临床麻醉学杂志, 2022, 38(6): 654-657. |
CHEN H, LIU C M. Progress in the application of gastric ultrasonography in anesthesia in patients with delayed gastric emptying[J]. J Clin Anesthesiol, 2022, 38(6): 654-657. | |
[9] |
SMITH I, KRANKE P, MURAT I, et al. Perioperative fasting in adults and children: guidelines from the European Society of Anaesthesiology[J]. Eur J Anaesthesiol, 2011, 28(8): 556-569.
doi: 10.1016/j.eururo.2015.02.029 pmid: 25770484 |
[10] |
AMERICAN SOCIETY OF ANESTHESIOLOGISTS TASK FORCE ON ACUTE PAIN MANAGEMENT. Practice guidelines for acute pain management in the perioperative setting: an updated report by the American Society of Anesthesiologists Task Force on Acute Pain Management[J]. Anesthesiology, 2004, 100(6): 1573-1581.
doi: 10.1097/00000542-200406000-00033 pmid: 15166580 |
[11] | HAGLIND E, CARLSSON S, STRANNE J, et al. Urinary incontinence and erectile dysfunction after robotic versus open radical prostatectomy: a prospective, controlled, nonrandomised trial[J]. Eur Urol, 2015, 68(2): 216-225. |
[12] | AVERBECK M A, WOODHOUSE C, COMITER C, et al. Surgical treatment of post-prostatectomy stress urinary incontinence in adult men: report from the 6th International Consultation on Incontinence[J]. Neurourol Urodyn, 2019, 38(1): 398-406. |
[13] |
COMITER C. Surgery for postprostatectomy incontinence: which procedure for which patient?[J]. Nat Rev Urol, 2015, 12(2): 91-99.
doi: 10.1038/nrurol.2014.346 pmid: 25558839 |
[14] | 中华医学会泌尿外科学分会尿控学组. 男性压力性尿失禁诊断与治疗中国专家共识[J]. 中华泌尿外科杂志, 2022, 43(9): 641-645. |
Urology Control Group, Urology Branch of Chinese Medical Association. Chinese expert consensus on the diagnosis and treatment of male stress urinary incontinence[J]. Chin J Urol, 2022, 43(9): 641-645. | |
[15] |
CHANG J I, LAM V, PATEL M I. Preoperative pelvic floor muscle exercise and postprostatectomy incontinence: a systematic review and meta-analysis[J]. Eur Urol, 2016, 69(3): 460-467.
doi: 10.1016/j.eururo.2015.11.004 pmid: 26610857 |
[16] |
CANNING A, RAISON N, AYDIN A, et al. A systematic review of treatment options for post-prostatectomy incontinence[J]. World J Urol, 2022, 40(11): 2617-2626.
doi: 10.1007/s00345-022-04146-5 pmid: 36107210 |
[17] |
GOODE P S. Efficacy of an assisted low-intensity programme of perioperative pelvic floor muscle training in improving the recovery of continence after radical prostatectomy: a randomized controlled trial[J]. BJU Int, 2012, 110(7): 1010-1011.
doi: 10.1111/j.1464-410X.2012.11451.x pmid: 22909353 |
[18] |
PEREZ F S B, ROSA N C, DA ROCHA A F, et al. Effects of biofeedback in preventing urinary incontinence and erectile dysfunction after radical prostatectomy[J]. Front Oncol, 2018, 8: 20.
doi: 10.3389/fonc.2018.00020 pmid: 29535970 |
[19] |
CENTEMERO A, RIGATTI L, GIRAUDO D, et al. Preoperative pelvic floor muscle exercise for early continence after radical prostatectomy: a randomised controlled study[J]. Eur Urol, 2010, 57(6): 1039-1043.
doi: 10.1016/j.eururo.2010.02.028 pmid: 20227168 |
[20] | GEZGINCI E, GOKTAS S, ATA A. Effect of perioperative pelvic floor muscle training program on incontinence and quality of life after radical prostatectomy: a randomized controlled trial[J]. Clin Rehabil, 2023, 37(4): 534-544. |
[21] |
GERAERTS I, VAN POPPEL H, DEVOOGDT N, et al. Influence of preoperative and postoperative pelvic floor muscle training (PFMT) compared with postoperative PFMT on urinary incontinence after radical prostatectomy: a randomized controlled trial[J]. Eur Urol, 2013, 64(5): 766-772.
doi: 10.1016/j.eururo.2013.01.013 pmid: 23357349 |
[22] | GOMES C S, PEDRIALI F R, URBANO M R, et al. The effects of pilates method on pelvic floor muscle strength in patients with post-prostatectomy urinary incontinence: a randomized clinical trial[J]. Neurourol Urodyn, 2018, 37(1): 346-353. |
[23] |
SANDHU J S, BREYER B, COMITER C, et al. Incontinence after prostate treatment: AUA/SUFU guideline[J]. J Urol, 2019, 202(2): 369-378.
doi: 10.1097/JU.0000000000000314 pmid: 31059663 |
[24] | YU K, BU F, JIAN T T, et al. Urinary incontinence rehabilitation of after radical prostatectomy: a systematic review and network meta-analysis[J]. Front Oncol, 2023, 13: 1307434. |
[25] | 杨柏帅, 叶定伟, 姚旭东, 等. 前列腺癌根治术后电针联合提肛训练对改善尿控的研究[J]. 中华外科杂志, 2010, 48(17): 1325-1327. |
YANG B S, YE D W, YAO X D, et al. The study of electrical acupuncture stimulation therapy combined with pelvic floor muscle therapy for postprostatectomy incontinence[J]. Chin J Surg, 2010, 48(17): 1325-1327. | |
[26] | HSU L F, LIAO Y M, LAI F C, et al. Beneficial effects of biofeedback-assisted pelvic floor muscle training in patients with urinary incontinence after radical prostatectomy: a systematic review and metaanalysis[J]. Int J Nurs Stud, 2016, 60: 99-111. |
[27] |
MONTORSI F, NATHAN H P, MCCULLOUGH A, et al. Tadalafil in the treatment of erectile dysfunction following bilateral nerve sparing radical retropubic prostatectomy: a randomized, double-blind, placebo controlled trial[J]. J Urol, 2004, 172(3): 1036-1041.
doi: 10.1097/01.ju.0000136448.71773.2b pmid: 15311032 |
[28] |
GOH H J, SUNG J M, LEE K H, et al. Efficacy of phosphodiesterase type 5 inhibitors in patients with erectile dysfunction after nerve-sparing radical prostatectomy: a systematic review and meta-analysis[J]. Transl Androl Urol, 2022, 11(2): 124-138.
doi: 10.21037/tau-21-881 pmid: 35280664 |
[29] |
MONTORSI F, BROCK G, STOLZENBURG J U, et al. Effects of tadalafil treatment on erectile function recovery following bilateral nerve-sparing radical prostatectomy: a randomised placebo-controlled study (REACTT)[J]. Eur Urol, 2014, 65(3): 587-596.
doi: 10.1016/j.eururo.2013.09.051 pmid: 24169081 |
[30] | LIN Y H, YU T J, LIN V C, et al. Effects of early pelvic-floor muscle exercise for sexual dysfunction in radical prostatectomy recipients[J]. Cancer Nurs, 2012, 35(2): 106-114. |
[31] |
PROTA C, GOMES C M, RIBEIRO L H, et al. Early postoperative pelvic-floor biofeedback improves erectile function in men undergoing radical prostatectomy: a prospective, randomized, controlled trial[J]. Int J Impot Res, 2012, 24(5): 174-178.
doi: 10.1038/ijir.2012.11 pmid: 22573231 |
[32] | 中国抗癌协会肿瘤营养专业委员会, 中华医学会肠外肠内营养学分会组织. 中国肿瘤营养治疗指南-2020[M]. 北京: 人民卫生出版社, 2020. |
Organized by the Tumor Nutrition Professional Committee of the Chinese Anti-Cancer Association and the Parenteral Nutrition Branch of the Chinese Medical Association. Chinese cancer nutritional therapy guidebook-2020[M]. Beijing: People’s Health Publishing House, 2020. | |
[33] |
MAGHELI A, KNOLL N, LEIN M, et al. Impact of fast-track postoperative care on intestinal function, pain, and length of hospital stay after laparoscopic radical prostatectomy[J]. J Endourol, 2011, 25(7): 1143-1147.
doi: 10.1089/end.2011.0020 pmid: 21740262 |
[1] | PAN Jian, YE Dingwei, ZHU Yao, WANG Beihe. Correlation analysis of PSMA PET/CT-derived parameters and circulating tumor DNA features in patients with hormone-sensitive prostate cancer [J]. China Oncology, 2024, 34(7): 680-685. |
[2] | Cancer Nuclear Medicine Committee of China Anti-Cancer Association, Chinese Association of Nuclear Medicine Physicians. Expert consensus of 177Lu-labeled PSMA radioligand therapy for clinical practice of prostate cancer (2024 edition) [J]. China Oncology, 2024, 34(7): 702-714. |
[3] | Professional Committee on Gastric Cancer of Shanghai Anticancer Association , Professional Committee on Gastrointestinal Cancer of China Association for Promotion of Health Science and Technology . Chinese expert consensus on clinical practice of locally advanced gastric cancer invading adjacent organs (2024 edition) [J]. China Oncology, 2024, 34(5): 517-526. |
[4] | Committee of Breast Cancer Society, China Anti-Cancer Association. Expert consensus on clinical applications of ovarian function suppression for Chinese women with early breast cancer (2024 edition) [J]. China Oncology, 2024, 34(3): 316-333. |
[5] | China Anti-Cancer Association Tumor Biomarker Professional Committee, Shanghai Anti-Cancer Association Tumor Biomarker Professional Committee. Expert consensus on population-based BRCA germline mutation screening in China (2024 edition) [J]. China Oncology, 2024, 34(2): 220-238. |
[6] | XUE Liqiong, GUO Ye, CHEN Libo. Expert consensus on the management of adverse events in patients receiving targeted agents for advanced thyroid cancer (2023 edition) [J]. China Oncology, 2023, 33(9): 879-888. |
[7] | Expert Committee on Immunotherapy of Chinese Society of Clinical Oncology , Professional Committee on Cancer Biotherapy of Shanghai Anticancer Association . Chinese expert consensus on clinical application of recombinant oncolytic adenovirus in the treatment of malignant tumors [J]. China Oncology, 2023, 33(5): 527-548. |
[8] | PAN Jian, ZHU Yao, DAI Bo, YE Dingwei. Advances in basic research, clinical diagnosis and treatment of prostate cancer in 2022 [J]. China Oncology, 2023, 33(3): 210-217. |
[9] | Society of Male Reproductive System Oncology, China Anti-Cancer Association. Expert consensus on perioperative comprehensive treatment for high risk prostate cancer (2023 edition) [J]. China Oncology, 2023, 33(12): 1204-1214. |
[10] | . Expert consensus on genetic counseling in gynecological oncology (2023 edition) [J]. China Oncology, 2023, 33(11): 1041-1064. |
[11] | YANG Wenbo, ZHANG Bin, WU Jiahui, CUI Jie. Current status and treatment direction of the immune microenvironment of castration-resistant prostate cancer [J]. China Oncology, 2023, 33(10): 945-953. |
[12] | Committee of Breast Cancer Society, Chinese Anti-Cancer Association, Breast Surgeons Committee of Surgeons Branch, Chinese Medical Doctor Association, Committee of Breast Cancer Society, Shanghai Anti-Cancer Association. Expert consensus on oncoplastic surgery of breast tumor and breast reconstruction (2022 edition) [J]. China Oncology, 2022, 32(9): 836-924. |
[13] | ZHOU Shukui, ZHANG Dongliang, WANG Xiang, LIU Lei, LI Zeng, YANG Shengke, LIAO Hong. Developing a new animal model of subcutaneous transplanted prostate cancer with cell sheet technology [J]. China Oncology, 2022, 32(3): 200-206. |
[14] | ZHOU Bingni, LIU Xiaohang, GU Bingxin, ZHOU Liangping, GU Yajia. The value of mpMRI combined with 99mTc-PSMA SPECT/CT in the detection of significant residual prostate cancer after neoadjuvant androgen deprivation therapy [J]. China Oncology, 2022, 32(2): 134-141. |
[15] | Chinese Anti-Cancer Association, Committee of Breast Cancer Society. Expert consensus on clinical applications of ovarian function suppression for Chinese women with early breast cancer 2021 CACA-CBCS [J]. China Oncology, 2022, 32(2): 177-190. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||
沪ICP备12009617
Powered by Beijing Magtech Co. Ltd